Sex hormones, inflammation and the metabolic syndrome: A population-based study

European Journal of Endocrinology

Volumn 149, Issue 6, 2003, Pages 601-608

  Laaksonen, David E ^a,b   Niskanen, Leo ^a   Punnonen, Kari ^a   Nyyssönen, Kristiina ^b   Tuomainen, Tomi Pekka ^b   Salonen, Riitta ^b   Rauramaa, Rainer ^a,b   Salonen, Jukka T ^b,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Inner Savo Health Centre   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CALCULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; GENDER; GLUCOSE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

EID: 0346728590     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490601     Document Type: Article

References (43)

1. Phillips GB. Sex hormones, risk factors and cardiovascular disease. American Journal of Medicine 1978 65 7-11.
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607.
3. Liese AD, Mayer-Davis EJ & Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiology Review 1998 20 157-172.
4. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT & Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 2002 156 1070-1077.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002 288 2709-2716.
6. Bouchard C. Genetics and the metabolic syndrome. International Journal of Obesity and Related Metabolic Disorders 1995 19 (Suppl 1) S52-S59.
7. Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R & Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002 25 1612-1618.
8. Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint-Paul M, Nahoul K et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 1992 35 173-177.
9. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993 42 116-120.
10. Haffner SM, Karhapaa P, Mykkanen L & Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 1994 43 212-219.
11. Haffner SM, Valdez RA, Mykkanen L, Stern MP & Katz MS. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994 43 599-603.
12. Phillips GB, Jing T & Heymsfield SB. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003 52 784-790.
13. Haffner SM, Mykkanen L, Valdez RA & Katz MS. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. Journal of Clinical Endocrinology and Metabolism 1993 77 1610-1615.
14. Tsai EC, Boyko EJ, Leonetti DL & Fujimoto WY. Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. International Journal of Obesity and Related Metabolic Disorders 2000 24 485-491.
15. Haffner SM, Shaten J, Stern MP, Smith GD & Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. American Journal of Epidemiology 1996 143 889-897.
16. Tibblin G, Adlerberth A, Lindstedt G & Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996 45 1605-1609.
17. Oh J-Y, Barrett-Connor E, Wedick NM & Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002 25 55-60.
18. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. International Journal of Obesity and Related Metabolic Disorders 1992 16 991-997.
19. Walker BR. Steroid metabolism in metabolic syndrome X. Best Practice and Research in Clinical Endocrinology and Metabolism 2001 15 111-122.
20. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism 2001 86 1418-1421.
21. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Annals of Clinical Research 1988 20 46-50.
22. Vermeulen A. Andropause. Maturitas 2000 34 5-15.
23. Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, Niskanen LK et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabetic Medicine 2002 19 456-464.
24. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA & Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation 2000 102 2677-2679.
25. Tuomainen TP, Punnonen K, Nyyssonen K & Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998 97 1461-1466.
26. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553.
27. Balkau B & Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetic Medicine 1999 16 442-443.
28. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 683-689.
29. National Cholesterol Education Program, Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
30. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J & Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. New England Journal of Medicine 1994 330 1549-1554.
31. Cundy T, Butler J, Bomford A & Williams R. Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clinical Endocrinology 1993 38 617-620.
32. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N et al. Testosterone dose-response relationships in healthy young men. American Journal of Physiology, Endocrinology and Metabolism 2001 281 E1172-E1181.
33. Khaw KT & Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. Journal of Hypertension 1988 6 329-332.
34. Wu FC & Von Eckardstein A. Androgens and coronary artery disease. Endocrinological Reviews 2003 24 183-217.
35. Davani B, Khan A, Hult M, Martensson E, Okret S, Efendic S et al. Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. Journal of Biological Chemistry 2000 275 34841-34844.
36. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001 294 2166-2170.
37. Dotsch J & Rascher W. The role of 11beta-hydroxysteroid dehydrogenase activity in the metabolic syndrome: lessons learned from the animal model. European Journal of Endocrinology 2002 146 603-605.
38. Stellato RK, Feldman HA, Hamdy O, Horton ES & McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000 23 490-494.
39. Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S, Chierici R et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. Journal of Clinical Endocrinology and Metabolism 1995 80 654-658.
40. Nestler JE, Whitfield JB, Williams TY, Zhu G, Condon J, Kirk KM et al. Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects. Journal of Clinical Endocrinology and Metabolism 2002 87 682-686.
41. Schunkert H, Hense H-W, Andus T, Riegger GAJ & Straub RH. Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample. American Journal of Hypertension 1999 12 1140-1143.
42. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672.
43. Wheeler MJ. The determination of bio-available testosterone. Annals of Clinical Biochemistry 1995 32 345-357.